Biomarkers associated with the development of comorbidities in atopic dermatitis (AD)
patients have been reported, but have not yet been systematically reviewed. Seven …

Background Responses to the systemic treatments commonly used to treat psoriasis vary.
Biomarkers that accurately predict effectiveness and safety would enable targeted treatment …

Allergic diseases and asthma are intrinsically linked to the environment we live in and to
patterns of exposure. The integrated approach to understanding the effects of exposures on …

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease in the general
population. Skin barrier dysfunction is the central abnormality leading to AD. The cause of …

Background Chronic inflammatory skin diseases such as atopic dermatitis (AD) and
psoriasis (PSO) present major challenges in health care. Thus, biomarkers to identify …

Immune mediated inflammatory diseases (IMIDs) are a heterogeneous group of debilitating,
multifactorial and unrelated conditions featured by a dysregulated immune response leading …

More severe atopic dermatitis and psoriasis are associated with a higher cumulative impact
on quality of life, multimorbidity and healthcare costs. Proactive, early intervention in those …

This qualitative study examines the impact of scientific, ethical, and translational challenges
of precision medicine for atopic dermatitis and psoriasis. The study explores how these …

Introduction Psoriasis, atopic dermatitis and contact dermatitis are common chronic
inflammatory skin diseases that have a significant impact on individuals and society …

More severe atopic dermatitis and psoriasis are associated with a higher cumulative impact
on quality of life, multimorbidity and healthcare costs. Proactive, early intervention in those …